Evidence map›Paper›PMID 36052304›Full record

Trial reportInternational journal of clinical practice2022

Effect of Vitamin D Supplementation on Inflammatory Biomarkers in School-Aged Children with Attention Deficit Hyperactivity Disorder.

Mahsa Samadi, Fatemeh Gholami, Marzieh Seyedi, Mahmoud Jalali, Mohammad Effatpanah, Mir Saeid Yekaninejad, Mina Abdolahi, Maryam Chamari, Niyaz Mohammadzadeh Honarvar

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in International journal of clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mahsa SamadiDepartment of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-0827-4810
Fatemeh GholamiDepartment of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-8444-3794
Marzieh SeyediDepartment of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-2859-6718
Mahmoud JalaliDepartment of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad EffatpanahSchool of Medicine, Ziaeian Hospital, International Campus, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-5344-7699
Mir Saeid YekaninejadDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Science, Tehran, Iran.
Mina AbdolahiDepartment of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
Maryam ChamariDepartment of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-7040-0868
Niyaz Mohammadzadeh HonarvarDepartment of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-8939-2247
Tehran University of Medical Sciences · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Method: This randomized double-blind, placebo-controlled trial was conducted on 75 school-aged children with a diagnosis of ADHD based on DSM-V criteria. Children were randomly allocated to receive either vitamin D3 (2000 IU/day) or a placebo for 3 months. Serum IL-6, TNF- Results: Serum levels of 25(OH) D increased significantly in the vitamin D group ( Conclusion: The findings revealed that vitamin D supplementation for 3 months is not efficacious in reducing inflammatory cytokines in children with ADHD. Further studies are required to confirm these results.

Indexed as

Attention Deficit Disorder with HyperactivityBiomarkersChildDietary SupplementsDouble-Blind MethodHumansInterleukin-6Tumor Necrosis Factor-alphaVitamin DBiomarkersInterleukin-6Tumor Necrosis Factor-alphaVitamin D

Identifiers

PMID36052304
PMCPMC9423974
OpenAlexW4292674474

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.